These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

994 related items for PubMed ID: 30664175

  • 1. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition.
    Liu T, Li A, Xu Y, Xin Y.
    Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175
    [Abstract] [Full Text] [Related]

  • 2. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.
    Bi Y, Li H, Yi D, Sun Y, Bai Y, Zhong S, Song Y, Zhao G, Chen Y.
    Mol Pharm; 2018 Nov 05; 15(11):4912-4925. PubMed ID: 30336060
    [Abstract] [Full Text] [Related]

  • 3. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
    Li H, Chen L, Li JJ, Zhou Q, Huang A, Liu WW, Wang K, Gao L, Qi ST, Lu YT.
    J Hematol Oncol; 2018 May 29; 11(1):70. PubMed ID: 29843746
    [Abstract] [Full Text] [Related]

  • 4. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G.
    Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279
    [Abstract] [Full Text] [Related]

  • 5. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N.
    J Exp Clin Cancer Res; 2019 Jun 18; 38(1):266. PubMed ID: 31215502
    [Abstract] [Full Text] [Related]

  • 6. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z, Jiang X, Gao L, Liu X, Li J, Huang X, Zeng T.
    World Neurosurg; 2019 Aug 18; 128():e468-e477. PubMed ID: 31048057
    [Abstract] [Full Text] [Related]

  • 7. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
    Guo G, Sun Y, Hong R, Xiong J, Lu Y, Liu Y, Lu J, Zhang Z, Guo C, Nan Y, Huang Q.
    Clin Transl Oncol; 2020 Aug 18; 22(8):1252-1262. PubMed ID: 31865606
    [Abstract] [Full Text] [Related]

  • 8. Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide.
    Johannessen TC, Hasan-Olive MM, Zhu H, Denisova O, Grudic A, Latif MA, Saed H, Varughese JK, Røsland GV, Yang N, Sundstrøm T, Nordal A, Tronstad KJ, Wang J, Lund-Johansen M, Simonsen A, Janji B, Westermarck J, Bjerkvig R, Prestegarden L.
    Int J Cancer; 2019 Apr 01; 144(7):1735-1745. PubMed ID: 30289977
    [Abstract] [Full Text] [Related]

  • 9. Rutin increases the cytotoxicity of temozolomide in glioblastoma via autophagy inhibition.
    Zhang P, Sun S, Li N, Ho ASW, Kiang KMY, Zhang X, Cheng YS, Poon MW, Lee D, Pu JKS, Leung GKK.
    J Neurooncol; 2017 May 01; 132(3):393-400. PubMed ID: 28293765
    [Abstract] [Full Text] [Related]

  • 10. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.
    Li Z, Zhang J, Zheng H, Li C, Xiong J, Wang W, Bao H, Jin H, Liang P.
    J Exp Clin Cancer Res; 2019 Aug 28; 38(1):380. PubMed ID: 31462285
    [Abstract] [Full Text] [Related]

  • 11. Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway.
    Xu P, Wang H, Pan H, Chen J, Deng C.
    Cancer Chemother Pharmacol; 2022 Feb 28; 89(2):183-196. PubMed ID: 34997858
    [Abstract] [Full Text] [Related]

  • 12. Neuropilin-1 enhances temozolomide resistance in glioblastoma via the STAT1/p53/p21 axis.
    Huang P, Zhang L, Wang H, Dou C, Ju H, Yue P, Ren J.
    Neuropathology; 2024 Aug 28; 44(4):319-330. PubMed ID: 38448392
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression.
    Yu Z, Chen Y, Wang S, Li P, Zhou G, Yuan Y.
    Cancer Lett; 2018 Aug 01; 428():77-89. PubMed ID: 29705182
    [Abstract] [Full Text] [Related]

  • 14. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X, Wang M, Zuo J, Wahafu A, Mao P, Li R, Wu W, Xie W, Wang J.
    Life Sci; 2019 Nov 01; 236():116917. PubMed ID: 31614149
    [Abstract] [Full Text] [Related]

  • 15. A combined preclinical therapy of cannabinoids and temozolomide against glioma.
    Torres S, Lorente M, Rodríguez-Fornés F, Hernández-Tiedra S, Salazar M, García-Taboada E, Barcia J, Guzmán M, Velasco G.
    Mol Cancer Ther; 2011 Jan 01; 10(1):90-103. PubMed ID: 21220494
    [Abstract] [Full Text] [Related]

  • 16. TTK Protein Kinase promotes temozolomide resistance through inducing autophagy in glioblastoma.
    Yu J, Gao G, Wei X, Wang Y.
    BMC Cancer; 2022 Jul 18; 22(1):786. PubMed ID: 35850753
    [Abstract] [Full Text] [Related]

  • 17. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
    Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH, Lin YF, Shih CM.
    Free Radic Biol Med; 2012 Jan 15; 52(2):377-91. PubMed ID: 22094224
    [Abstract] [Full Text] [Related]

  • 18. Micro-RNA29b enhances the sensitivity of glioblastoma multiforme cells to temozolomide by promoting autophagy.
    Xu JX, Yang Y, Zhang X, Luan XP.
    Anat Rec (Hoboken); 2021 Feb 15; 304(2):342-352. PubMed ID: 32275350
    [Abstract] [Full Text] [Related]

  • 19. Low-Dose DMC Significantly Enhances the Effect of TMZ on Glioma Cells by Targeting Multiple Signaling Pathways Both In Vivo and In Vitro.
    Shi L, Sun G.
    Neuromolecular Med; 2015 Dec 15; 17(4):431-42. PubMed ID: 26458914
    [Abstract] [Full Text] [Related]

  • 20. Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation.
    Wu M, Song D, Li H, Ahmad N, Xu H, Yang X, Wang Q, Cheng X, Deng S, Shu X.
    Int J Mol Sci; 2023 May 29; 24(11):. PubMed ID: 37298405
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.